Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001966716-26-000002

Options or other derivatives

  • GENERAL COUNSEL & CORP SEC acquired 88,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Allan Jonathan GENERAL COUNSEL & CORP SEC 2026-02-17 Grant or award · Employee Stock Option (Right to Buy) +53,000 53,000 D
Allan Jonathan GENERAL COUNSEL & CORP SEC 2026-02-17 Grant or award · Restricted Stock Units +35,000 35,000 D
Loading xslF345X05/form4-02192026_090202.xml…